IDA only vs Saudi Arabia: Access to anti-retroviral drugs, male
IDA only
80.4%
in 2024
Saudi Arabia
93.0%
in 2024
IDA only rank
4th
Saudi Arabia rank
7th
Access to anti-retroviral drugs, male over time
- IDA only
- Saudi Arabia
How they compare
Saudi Arabia currently reports 93.0% against 80.4% in IDA only, a difference of 12.6%.
That makes Saudi Arabia's figure about 1.2 times IDA only's.
Across all 25 years both countries report, Saudi Arabia has been ahead every year.
IDA only ranks 4th and Saudi Arabia ranks 7th of 19 groups.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA only | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.7% | 27.0% | 21.3% | Saudi Arabia |
| 2010s | 39.9% | 56.4% | 16.5% | Saudi Arabia |
| 2020s | 73.0% | 91.2% | 18.2% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, IDA only or Saudi Arabia?
- Saudi Arabia, at 93.0% against 80.4% in IDA only as of 2024.
- What is the difference in access to anti-retroviral drugs, male between IDA only and Saudi Arabia?
- 12.6%, with Saudi Arabia ahead.
- How many years of comparable data are there for IDA only and Saudi Arabia?
- 25 years are reported by both, from 2000 to 2024.
- How do IDA only and Saudi Arabia rank globally for access to anti-retroviral drugs, male?
- IDA only ranks 4th and Saudi Arabia ranks 7th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.